Optimum Immunosuppression in Renal Transplant Recipients.New Onset Diabetes After Transplantation
A phase 4 trial registered on ClinicalTrials.gov. The registry status is terminated. It enrolled 134 participants.
Also called NCT01002339
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose prevention
- Phase
- Phase 4
- Enrolled
- 134 participants
- Sponsor
- Armando Torres Ramírez
- Registry
-
NCT01002339
-
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- Spain
- Registry status
- Terminated
Technical summary
Registry record NCT01002339. Randomized; no masking; primary purpose prevention. Start 2010-02 (registry gives no type); primary completion 2014-02 (actual). Results posted on 2016-08-03.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Optimum Immunosuppression in Renal Transplant Recipients.New Onset Diabetes After Transplantation
- Acronym
- 01-DMPT
- Condition
- Diabetes Mellitus, Adult-Onset
- Intervention (Drug)
- Tacrolimus with rapid steroid withdrawal
- Intervention (Drug)
- Tacrolimus with steroids minimization
- Intervention (Drug)
- CsA with steroid minimization
- Lead sponsor
- Armando Torres Ramírez
Record details
- Record id
cardio:ct-nct01002339- Content hash
5139524d20084412dee4417d50bc4b95f0ac3f0a4b628ae3b56652c41ecbbd88